The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

November 10, 2021 • By Lisa Stamp, MBChB, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

This study provides further evidence that incident gout is uncommon over a two-year period, even in those with hyperuricemia, and that there is no benefit to the use of ULT to prevent incident gout.

You Might Also Like
  • Dr. Blair Solow’s Picks for the Top RA Research Presented at ACR Convergence 2020
  • Dr. Ethan Craig Picks His Favorite Gout Abstracts from ACR Convergence 2020
  • Top Research in Lupus Presented at ACR Convergence 2020
Explore This Issue
December 2021

Abstract 0674: A behavioral intervention to improve gout outcomes in African Americans with gout: A 12-month multicenter, randomized controlled trial6

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Research by Singh J, et al.

Gout is one of the most common forms of arthritis and disproportionately affects Indigenous peoples and minority populations. Although gout is eminently treatable, it is, in general, poorly managed, resulting in poor outcomes. Indigenous and minority populations are under-represented in clinical trials, particularly industry-sponsored trials, required for regulatory approval.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Although this study showed no benefit from the culturally appropriate gout storytelling intervention, it is heartening to see research specifically focused on this area. As the authors conclude, we need more research to develop effective, culturally appropriate interventions to improve outcomes for Indigenous peoples and minority populations with gout.

Abstract 1897: A randomized double-blind controlled trial of intensive serum urate lowering with oral urate-lowering therapy for erosive gout7

Research by Dalbeth N, et al. (Author’s note: I am an author on this abstract.)

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Intensive ULT with pegloticase has improved bone erosion in people with gout. However, pegloticase typically reduces serum urate concentrations to much lower levels than oral urate-lowering therapies do, and it is currently a last-line therapy for most patients.

In this two-year randomized, controlled trial, oral ULTs were utilized in a standard protocol and participants were randomized to a target urate of 3.4–4.9 mg/dL (0.20–0.29 mmol/L) or 1.7–3.2 mg/dL (0.10–0.19 mmol/L). Using oral ULT, the lower serum urate target was more difficult to achieve, the medication burden was substantial, and there was no improvement in bone erosion scores.

The current 2020 ACR guideline recommends a target serum urate concentration of <0.36 mmol/L (6 mg/dL) for all people with gout. And in comparison to the 2012 guidelines, no recommendation about a lower target was made for those with more advanced disease, such as tophi or bone erosions.

Conclusion

The research presented at ACR Convergence 2021 shows that clinicians still have work to do to help our patients manage their gout and that urate-lowering therapy can help in the treatment and prevention of gout.


Lisa Stamp, MBChB, PhD, is a rheumatologist, professor of medicine and the associate dean of research at the University of Otago, Christchurch, New Zealand. She has extensively researched the pathophysiology and management of gout.

Pages: 1 2 3 4 | Single Page

Filed Under: ACR Convergence, Conditions, Crystal Arthritis, Meeting Reports Tagged With: ACR Convergence – Gout, ACR Convergence 2021, ACR Convergence 2021 – GoutIssue: December 2021

You Might Also Like:
  • Dr. Blair Solow’s Picks for the Top RA Research Presented at ACR Convergence 2020
  • Dr. Ethan Craig Picks His Favorite Gout Abstracts from ACR Convergence 2020
  • Top Research in Lupus Presented at ACR Convergence 2020
  • Updates on ACR Gout Guideline, FDA’s Febuxostat Warning & Pegloticase Therapy

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)